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Biosynthesis	of	 glycogen,	 the	essential	 glucose	 (and	hence	energy)	 storage	molecule	 in	humans,	
animals	 and	 fungi,
1
	 is	 initiated	 by	 glycosyltransferase	 enzyme	 glycogenin	 (GYG)	 (ED	 Figure	 1).	
Deficiencies	 in	 glycogen	 formation	 cause	 neurodegenerative	 and	 metabolic	 disease	 (ED	 Figure	
1b).
2-4
	Mouse	knockout
5
	and	 inherited	human	mutations
6
	of	GYG	impair	glycogen	synthesis.	GYG	
acts	as	a	‘seed	core’	for	the	formation	of	the	glycogen	particle	by	catalyzing	its	own	stepwise	auto-
glucosylation	to	form	a	covalently-bound	gluco-oligosaccharide	chain	at	 initiation	site	Tyr195.	To	
date,	an	inability	to	access	homogeneous	glycoforms	of	this	protein,	which	unusually	acts	as	both	
catalyst	 and	 substrate,	 has	 precluded	 precise	 mechanistic	 studies.	 Here	 we	 show	 that,	
unprecedented,	 direct	 access	 to	 different,	 homogeneously	 glucosylated	 states	 of	 GYG	 can	 be	
accomplished	 through	a	palladium-mediated	enzyme	activation	 ‘shunt’	process	using	on-protein	
C–C	 bond-formation.	 Careful	 mimicry	 of	 GYG	 intermediates	 recapitulates	 catalytic	 activity	 at	
distinct	 stages,	 which	 in	 turn	 allows	 discovery	 of	 tri-phasic	 kinetics	 and	 substrate	 plasticity	 in	
GYG’s	use	of	sugar	substrates.	This	 reveals	a	 tolerant	but	 ‘proof-read’	mechanism	that	underlies	
the	precision	of	 this	 vital	metabolic	process.	 This	demonstration	of	direct,	 chemically-controlled	
access	to	 intermediate	states	of	active	enzymes	suggests	that	such	ligation-dependent	activation	
could	be	a	powerful	tool	in	the	study	of	mechanism.		
The	initial	anchor	point	for	the	dendron-like	structures	that	make	up	glycogen	is	the	Tyr195	
residue	of	GYG	(GYG1	numbering);	glycogenesis	 is	 therefore	a	striking	example	of	α-linked	protein	
autoglucosylation.7	 Prior	 studies	 have	 suggested	 GYG	 to	 be	 a	 dimeric,8	 Mn2+-dependent	 enzyme	
belonging	 to	 the	 GT-8	 family	 of	 retaining	 glycosyltransferases.9,10	 GYG	 is	 –	 by	 virtue	 of	 its	 self-
modifying	nature	–	non-identical	for	each	glucosylation	step;	i.e.	GYG,	unlike	nearly	all	biosynthetic	
enzymes,	 is	 strictly	 not	 a	 catalyst	 since	 it	 is	 itself	 changed	 at	 each	 step.	 This	 leads	 potentially	 to	
altered	activity	 for	 each	 intermediate	 state	 and	presumably	 to	 eventual	 inactivity	once	 ‘buried’	 in	
glycan.	 This	 opens	 up	 the	 unusual	 possibility	 of	 distinct	 sub-phases	 and	mechanisms	 occurring	 at	
different	 oligosaccharide	 chain	 lengths;	 crystal	 structures	 suggest	 possible	 intra-monomeric	 and	
inter-monomeric	 glucosylation	 modes	 within	 the	 GYG	 protein	 dimer.10	 Whilst	 bespoke	
biosynthetically-deficient	expression	host	strains	can	generate	a	glycan-free,	starting	form	of	GYG,11	
this	 allows	 access	 to	 only	 one	 catalyst	 state	 (Supplementary	 Text).	 As	 a	 result,	 any	 possible	
‘(sub)phases’	subsequent	to	this	starting	state	may	be	obscured	if	they	follow	faster	kinetics.	A	lack	
of	access	to	homogeneous	GYG	catalyst	states	therefore	restricts	our	current	understanding.		
We	reasoned	that	chemical	construction	of	pure	GYG	in	different	glucosylation	states	might	
allow	 a	 strategy	 for	 direct,	 guided	 (‘shunted’)	 activation	 (and	 hence	 interrogation)	 of	 chosen	
intermediate	 states	 (Figure	 1	 and	 ED	 Figures	 1c,2a).	 The	 unusual	 hybrid	 nature	 of	 these	 catalyst	
states	 –	 part-catalyst-part-substrate	 –	 suggested	 a	 convergent	 (tag-and-modify12)	 construction	
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process	in	which	the	desired	(glycosyl	acceptor)	glycan	moiety	would	be	covalently	attached	in	one-
step	to	key	catalytic	site	195	(ED	Figure	1c).	We	have	previously	demonstrated	that	Pd(0)-mediated	
C–C-bond	 forming	 ligation	 is	 feasible	 and	 benign	 in	 certain	 biological	 contexts.13-17	 Pd-mediated	
approaches	in	biology	have	since	been	elegantly	exploited	by	various	groups.18-20	However,	GYG	is	a	
testing	 target	biomolecule	on	which	 to	apply	 this	method.	Not	only	 is	 site	195	 in	 the	heart	of	 the	
active	 site,	 but	GYG	 is	 also	metal-dependent,	 raising	 the	possibility	 of	 inhibitory	 ‘poisoning’	 cross-
competition21,22	by	Pd	at	the	metal	co-factor	site.		
A	suitable	precursor	GYG1	bearing	a	 reactive	 ‘tag’	 for	Pd(0)-mediated	C–C	bond	 formation	
was	 generated	 via	 site-specific	 unnatural	 amino	 acid	 incorporation,14,23,24	 giving	 a	 variant	 in	which	
the	para-hydroxy	group	of	the	natural,	wild-type	(wt)	tyrosine	residue	at	site	195	was	exchanged	for	
an	 iodide	 atom	 (OH→I,	 GYG-Tyr195→GYG-pIPhe195,	 Figure	 1).	 Characterization	 confirmed	 no	
deleterious	 effects	 on	 overall	 enzyme	 structure.	 The	 structure	 of	 GYG-Y195pIPhe,	 determined	 in	
both	 apo	 (2.2	 Å)	 and	Mn2++UDP	 bound	 (2.4	 Å)	 states	 (Supplementary	 Table	 S1),	 revealed	 highly	
superimposable	dimers	to	those	in	GYG-wt10	(ED	Figure	2c).	In	the	ligand-bound	state,	the	pIPhe195	
group	from	one	monomer	is	clearly	visible	(ED	Figure	2d,	inset),	located	within	a	partially	unwound	
helix	 that	 adopts	 a	 catalytically	 poised	 position	 equidistant	 to	 either	 active	 site	 of	 the	 dimer	 (ED	
Figure	2d,	red).	Asymmetry	at	the	dimer	interface,	consistent	with	previous	unglucosylated	GYG-wt	
structures10,	suggested	likely	conformational	flexibility	needed	as	GYG	transitions	from	unconjugated	
to	differently	glucosylated	forms.	
Studies	on	wild-type	GYG	(GYG-wt	/	GYG-Tyr195)	revealed	concentration-dependence	of	Pd	
inhibition	and	hence	determination	of	essentially	benign	Pd	concentrations	that	would	successfully	
allow	 preservation	 of	 enzymatic	 activity	 (ED	 Figure	 3	 and	 Supplementary	 Note);	 other	 cross-
coupling	components	had	minimal	effect.	These	conditions	allowed	successful	Pd-mediated	C(sp2)–
C(sp2)	ligation	of	GYG-pIPhe195	to	a	variety	of	designed,	systematically-altered	‘substrate	templates’	
(Figure	1	and	ED	Figure	2a,	4);	all	bore	nucleophilic,	hydroxyl	groups	as	possible	 reaction	sites	 for	
auto-glucosylation	 (readily	 prepared	 as	 their	 corresponding	 C(sp2)	 boronic	 acid	 derivatives	 1,	 see	
Supplementary	Methods).	 Small	 amounts	 of	 side-products	were	 also	 identified	 (ED	 Figure	 5):	 for	
example,	unreacted	GYG-pIPhe195	or	species	attributable	to	dehalogenation17	using	LC-MS	analysis	
and	negative	control	studies	(Supplementary	Methods	and	Supplementary	Text).	Despite	successful	
Pd-mediated	 ligation,	 ‘simple’	 glycan-mimic	 templates	 (ED	 Figure	 4)	 provided	 ineffective	mimicry:	
irrespective	 of	 systematically	 varied	 nature	 (orientation,	 length	 or	 pKA),	 none	 led	 to	 activation	 of	
autoglucosylation.	 Activation	 of	 GYG	 requires	 more	 than	 just	 an	 available	 hydroxyl	 nucleophile	
positioned	 in	 the	 active	 site.	 However,	 for	more	 complex	 substrate	 templates	 displaying	 glucosyl	
moieties	 inside	 GYG	 not	 only	 did	 protein	 LC-MS	 analysis	 reveal	 successful	 C–C	 ligation	 but	 also	
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concomitant	activation	and	clear	auto-glucosylation	activity	 in	the	resulting	 ‘shunted’	 intermediate	
product	 GYG-Glc	 as	 well	 as	 the	 more	 advanced,	 chain-extended	 shunted	 states	 GYG-Glc-Glc	 and	
GYG-Glc6	 (Figure	2	and	Supplementary	 Information).	Side-products	 from	cross-coupling	 (ED	Figure	
5)	were	inactive	to	autoglucosylation	and	thus	did	not	interfere	in	the	assay.			
This	chemically-generated	access	to	shunted	functionally-active	 intermediate	states	of	GYG	
along	 the	glycogen	biosynthetic	pathway	allowed	us	 to	uniquely	probe	and	compare	activity	using	
LC-MS-monitoring	of	the	sugars	attached	over	time	(Figure	2c,d,	ED	Figure	6,7	and	Supplementary	
Methods).	 Immediately	 contrasting	 behaviours	 from	 different	 states	 were	 observed.	 For	 more	
extended	GYG-Glc-Glc,	two	distinct	glucosylation	phases	were	apparent:	rapid	glucosylation	from	2	
until	~4-5	Glc	total,	then	significantly	slower	catalysis	thereafter	(Figure	2c,d).	Indeed,	the	initial	step	
(GYG-Glc-Glc→GYG-Glc-Glc-Glc)	 was	 extremely	 rapid;	 on-protein	 kinetic	 analyses	 conducted	 in	
replicate	(see	Supplementary	Methods)	revealed	that	~90%	of	starting	GYG-Glc-Glc	was	consumed	
within	 20	 seconds.	 In	 striking	 contrast,	 GYG-Glc	 exhibited	 a	more	 gradual	 decline	 in	 glucosylation	
rate	 with	 increasing	 oligosaccharide	 length	 (Figure	 2c,d),	 consistent	 with	 a	 significantly	 slower	
initiation	 sub-phase	 for	 GYG-Glc	 (GYG-Glc→GYG-Glc-Glc)	 that	 thus	 obscures	 the	 rapid	 phase	
immediately	following	(ED	Figure	6d).	Taken	together,	these	data	suggested	a	triphasic	mechanism,	
in	which	 a	 rapid	 intermediate	 phase	 is	 flanked	 by	 significantly	 slower	 initiation	 (<2	 glucoses)	 and	
elongation	(>	4/5	glucoses)	phases	(ED	Figure	6d).	Notably,	only	through	the	direct	‘shunt’	formation	
of	intermediates	(GYG-Glc,	GYG-Glc-Glc	etc)	achieved	through	Pd-mediated	ligation,	was	unobscured	
analysis	of	each	sub-phase	made	possible	(ED	Figure	7).	Clear	visualisation	of	this	kinetic	profile	was	
a	 consequence	 of	 our	 ability	 to	 both	 circumvent	 initial	 slow	 Tyr195	 glucosylation	 and	 also	 probe	
discrete	 glucosylation	 states	 immediately	 after	 this.	 The	 presence	 of	 distinct	 (sub)phases	 is	
consistent	with	the	proposed	existence	of	different	glucosylation	mechanisms	for	GYG10,25,26.		
Use	 of	 ‘shunted’	 intermediates	 GYG-Glc,	 GYG-Glc-Glc	 and	 GYG-Glc6	 allowed	 the	
determination	of	 initial	rates	that	gave	apparent	rate	constants	for	each	associated	phase	of	kapp	=	
0.016,	 0.126	 and	 0.003	 s-1,	 respectively	 (ED	 Figure	 7b).	 These	 were	 also	 compared	 directly	 with	
kinetics	determined	from	analysis	of	wild-type	GYG	in	unglucosylated	form	(GYG-wt-Glc0,	ED	Figure	
7).	As	expected,	 the	 inability	 to	access	 intermediate	 states	 for	GYG-wt	 failed	 to	 reveal	 the	distinct	
phases	 shown	by	our	chemically	 ‘shunted’	 system.	Nonetheless,	global	values	 for	 turnover	proved	
consistent;	 we	 now	 show	 that	 one	 consequence	 of	 the	 triphasic	 regime	 is	 an	 accumulation	 of	
glucosylation	 at	 the	 end	 of	 the	 fast	 phase	 2	 mechanism	 regime	 (lengths	 5-6	 Glc)	 going	 into	 the	
slower	 phase	 3.	 Taken	 together,	 this	 confirmed	 quantitative	mimicry	 at	 similar	 activity	 levels	 and	
highlighted	the	need	for	the	chemical	‘shunted’	approach	in	revealing	detailed	mechanism.	
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Quantum	 mechanics/molecular	 mechanics	 (QM/MM)	 metadynamics27,28	 simulations	 (see	
Supplementary	Methods)	allowed	further	insight	through	detailed	reconstruction	of	the	free-energy	
surface	 of	 reaction	 as	 a	 function	 of	 a	 few	 selected	 degrees	 of	 freedom	 (collective	 variables,	 CVs,	
Supplementary	Methods).	Michaelis	 complexes	equivalent	 to	GYG-Glc-Glc→GYG-Glc-Glc-Glc	 (both	
in	 wt,	 GYG-wt-Glc3→GYG-wt-Glc4,	 and	 shunted,	 GYG-Glc-Glc→GYG-Glc-Glc-Glc,	 form)	 were	
reconstructed	 from	 the	 structures	 determined	 here	 and	 of	 those	 in	 complex	 with	 UDP-Glc	 and	
cellotetraose.10	Both	wild-type	and	shunted	forms	gave	similar	results	(ED	Figure	8),	consistent	with	
kinetic	parameters.	The	free	energy	surface	revealed	a	short-lived	intermediate	(ED	Figure	9)	along	
the	 minimum	 free	 energy	 pathway	 indicative	 of	 a	 front-face,	 ‘SNi-like’	 reaction	 mechanism	 (see	
Supplementary	Video).29,30	 Notably,	 the	 free	 energy	 barrier	 ~10	 kcal/mol	was	 very	 low	 compared	
with	 typical	 values	 obtained	 previously	 for	 similar	 ‘SNi-like’	 glucosyl	 transfer	 reactions	 (~20	
kcal/mol30).	Thus,	together	our	kinetic	and	QM/MM	experimental	data	reveal	unprecedentedly	fast	
glycosyl-transfer	 for	 the	second	sub-phase	of	glycogen	 formation.	The	Michaelis	complex	 (R’	 in	ED	
Figure	9)	exhibits	a	near-perfect	approach	between	the	O4’-H	acceptor	bond	and	the	C1–OP	donor	
bond	to	assist	the	departure	of	UDP.	The	resulting	very	short	C1···O4‘	and	H···OP	distances	(3.3	and	
2.0	 Å,	 respectively,	 cf	3.2	 and	 2.5	 Å	 in	 prior,	 representative	 systems30)	 for	 formed	 bonds	 provide	
excellent	 stabilization	of	 charge	developed	at	 the	phosphate,	 together	with	proper	orientation	 for	
forthcoming	 front-face	 nucleophilic	 attack	 of	 O4‘	 onto	 C1	 of	 Glc.	 The	 acceptor	 O–H	 in	 GYG	 thus	
creates	 a	 direct	 hydrogen	 bond	 H···OP,	 unlike	 prior	 systems,	 resulting	 in	 a	more	 stretched	 sugar-
phosphate	bond	(C1–OP)	in	GYG	(1.58	Å	cf	1.51	Å
30)	with	a	much	lower	associated	bond-energy	(~10	
kcal/mol	cf	~18	kcal/mol).		
To	 probe	 the	 selectivities	 of	 this	 multiphasic	 GYG	 mechanism,	 we	 next	 investigated	 the	
potential	 of	GYG	 to	use	non-glucose	 sugar	 substrates.31	 The	potential	 for	GYG	 to	use	non-glucose	
acceptor	 sugar	moieties	 has	 not	 been	 examined	 due	 to	 the	 inability,	 until	 now,	 to	 directly	 access	
requisite	 intermediate	 enzyme	 states	 and	 to	 insert	 into	 those	 states	 non-glucose	 sugars.	 GYG-Glc	
and	GYG-Glc-Glc	generated	by	Pd-mediated	ligation	were	capable	of	utilising	the	non-glucose	donor	
sugar	 UDP-Galactose	 with	 kinetic	 profiles	 essentially	 qualitatively	 similar	 to	 analogous	 auto-
glucosylation	reactions	(Figure	3a)	thereby	forming	GYG-Glc-(Gal)n	and	GYG-Glc-Glc-(Gal)n.	Notably,	
however,	 the	 third	 kinetic	 (sub)phase	 observed	 for	 auto-glucosylation	 was	 curtailed	 for	 auto-
galactosylation	 (ED	 Figure	 6).	 Shunted	 access	 to	GYG	bearing	 common	non-glucose	 but	 naturally-
occurring	mammalian	monosaccharides	D-galactose	 (GYG-Gal)	 and	D-mannose	 (GYG-Man)	 (Figure	
3b	 and	 Supplementary	 Information,	 using	 boronic	 acid	 reagents	 1-Gal,	 1-Man)	 revealed,	
remarkably,	that	both	were	capable	of	auto-glucosylation	to	form	both	GYG-Gal-(Glc)n	etc	and	GYG-
Man-(Glc)n	 etc	 (Figure	 3c).	 Kinetic	 analyses	 of	 this	 non-glucose	 acceptor	 activity	 of	 GYG	 revealed	
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glucosylation	 rates	 for	 GYG-Gal	 and	 GYG-Man	 that	 are	 initially	 lower	 as	 a	 consequence	 of	 a	
significantly	slower	initiation	step	/	(sub)phase.	In	contrast	to	their	plasticity	towards	glucosylation,	
the	non-glucose	enzyme	states	GYG-Gal	and	GYG-Man	did	not	catalyse	auto-galactosylation	to	any	
significant	 extent	 (Supplementary	 Table	 12).	 Molecular	 dynamics	 (MD)	 simulations	 (ED	 Figure	 9)	
suggested	that,	strikingly,	the	altered	configurations	of	non-glucose	sugars,	e.g.	Gal	 in	GYG-Glc-Gal	
or	 UDP-Gal,	 necessitated	 slight	 reorientations	 but	 could	 be	 accommodated	 without	 significantly	
altering	the	interactions	at	the	active	site	with	key	hydroxyl-binding	residues.	The	result	 is	that	the	
distance	of	 the	putative	nucleophile	 (OH-4)	 from	the	electrophilic	anomeric	carbon	 (in	UDP-Gal	or	
UDP-Glc,	respectively)	is	not	greatly	perturbed	(O···C1	change	<	0.5Å)	and	O–C	bond	formation	can	
thus,	 unusually	 for	 GTs,	 evolve	 essentially	 ‘normally’	 despite	 such	 changes,	 reflecting	 this	
experimentally	observed	plasticity.		
Taken	together,	distinct	mechanistic	phases	of	GYG	(Figure	4)	are	therefore	defined	not	only	
by	differential	rates	but	also	different	donor/acceptor	tolerance.	Whilst	the	second,	rapid	phase	(2-
4/5	sugars)	readily	tolerates	Gal-to-Gal	transfer	throughout	(species	with	up	to	5	sugars	are	quickly	
generated	from	GYG-Glc-Glc),	the	first	and	third	phases	show	similarities	in	being	linked	by	not	only	
their	 slower	 glucosylation	 rates	 but	 also	 their	 apparent	 lower	 tolerance	 of	 non-glucose	 in	 both	
acceptor	and	donor	at	the	same	time.	A	plastic	and	rapid	second	phase	is	thus	seemingly	preceded	
by	 a	 slower	 step	 that	 can	 nonetheless	 be	 primed	with	 unnatural	 sugars	 –	 immediately	 surprising	
given	 the	presumed	 specific	 role	of	 glycogen	as	 a	 glucose-storage	polymer	–	 and	 is	 followed	by	 a	
slower	and	much	more	selective	third	phase.	Together	these	three	phases	appear	to	allow	‘priming’	
with	non-glucose	sugars	 in	the	first	phase	(e.g.	Gal,	Man)	followed	by	more	rapid	and	more	plastic	
‘extension’	in	the	second	phase	(with	either	UDP-Glc	or	UDP-Gal)	before	a	third	‘refining’	phase	that	
ensures	use	of	only	glucose	in	the	more	extended	portions	of	the	inner	core	of	glycogen.		
From	data	gathered	here	and	before,10	we	speculate	that	these	phases	may	reflect,	in	part,	
transitions	between	intra-monomeric	and	inter-monomeric	modes	of	glucosylation	within	the	active	
GYG	protein	dimer.	 From	our	 structure	of	GYG-pIPhe195	 the	 anchor	point	 for	 the	oligosaccharide	
chain	 of	 glycogen	 is	 essentially	 equidistant	 from	 the	 two	 active	 sites	 in	 GYG	 dimer.	 Molecular	
dynamics	(MD)	simulations	(ED	Figure	8)	with	GYG	bearing	Glc-oligomer	chains	of	different	lengths	
(GYG-Glcn,	n	=	0-5)	and	conformations	(intra-	/	inter-monomeric)	suggest	that	the	first	glucosylation	
steps	 (n	 =	 0,	 1)	 are	preferentially	 inter-monomeric.	A	 ‘blocking	 loop’	 inbetween	 the	 acceptor	 arm	
and	the	active	site	of	the	same	subunit	hampers	intra-monomeric	conformations.	In	contrast,	sugar	
chains	 of	 subsequent	 steps	 (n	 =	 2,	 3)	 circumvent	 the	 blocking	 loop,	 allowing	 intramonomeric	
conformations.	A	key	positioning	residue	GYG-Asp125	binds	the	nucleophilic	acceptor	Glc	terminus	
allowing	equilibration	 	 into	a	productive	Michaelis	complex	and	guides	 the	OH-4	 to	 the	donor	site	
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from	the	alpha	 face	of	UDP-Glc,	 ready	 for	 the	 front-face	attack	 (optimal	 for	 intermediate	 levels	of	
GYG	glucosylation).	Key	 to	 this	process	 is	a	striking	 flexibility	of	GYG-Tyr195,	which	steadily	 recoils	
step-by-step	by	 the	distance	of	one	sugar	 ring	 to	accommodate	acceptor	Glcn	 chains	of	 increasing	
lengths	(Figure	4).			
Together	these	data	suggest	a	first	inter-monomer	phase	where	the	nascent	oligosaccharide	
chain	is	of	insufficient	length	to	easily	provide	the	right	orientation	to	be	processed	by	the	active	site	
but	 can	 eventually	 equilibrate	 (‘hooked’	 into	 place	 by	Asp125)	 to	 a	 productive	Michaelis	 complex	
due	 to	 flexibility	 of	 Tyr195.	 In	 the	 second	 phase,	 sufficient	 flexibility	 of	 the	 oligosaccharide	 chain	
allows	correct	orientation	and	a	rapid	intra-monomer	extension,	yet	with	low	selectivity.	Finally,	 in	
the	 third	 ‘refining’	phase,	extension	of	 the	nascent	oligosaccharide	chain	past	 the	active	site	of	 its	
own	protein	monomer	 requires	extension	by	 the	active	 site	of	another	monomer	 in	a	much	more	
closely	linked	dimer	requiring	careful	alignment	of	donor	substrate	(UDP-Glc	only)	recruitment	with	
binding	 of	 the	 extending	 chain.	 Eventually,	 this	 chain	 too	 processes	 past	 the	 point	 of	 the	 second	
active	site	and	GYG’s	activity	ceases	at	a	 longer	chain	 length	of	>12	Glc	units.	This	presents	a	Glc-
terminated	 core-glycan	 particle	 ready	 for	 elaboration	 by	 Glycogen	 Synthase	 (GYS)	 and	 Glycogen	
Branching	Enzyme	(GBE),	respectively	(ED	Figure	1).1,32		
The	 plasticity	 of	 GYG	 raises	 the	 question	 of	 whether	 non-glucose	 sugars	 can	 ever	 be	
incorporated	into	mature	glycogen	particles.	Whilst	natural	incorporation	of	mannose	from	its	most	
abundant	 nucleotide	 GDP-mannose	 is	 not	 feasible	 owing	 to	 the	 known	 specificity	 of	 GYG	 for	
pyrimidine	nucleotide	 sugar	 donors,32	UDP-Gal	 is	 readily	 available	 in	 vivo.	 In	 this	 light,	 the	 limited	
final	 kinetic	phase	 for	auto-galactosylation	 is	 consistent	with	a	 ‘refining’	mechanism	 that	prevents	
mis-formed	glycogen	particles	due	 to,	 for	example,	poly-Gal	 incorporation	 (Figure	4).	At	 the	 same	
time,	GYG’s	ability	to	utilise	UDP-Gal	in	earlier	phases	may	facilitate	early	glycogenesis	during	times	
in	which	UDP-Glc	supplies	are	scarce.	Fascinatingly,	this	suggests	that	the	core	of	glycogen	can	carry	
priming	glycans	 that	may	be	non-glucose	 in	nature.	Our	work	here	also	highlights	 that	whilst	non-
glucose	 sugars	 might	 serve	 this	 role,	 other	 simpler	 hydroxyl-only	 templates	 fail.	 This,	 in	 turn,	
suggests	 that	 this	 core	 region	does	not	 serve	 a	 role	 as	 an	energy	 storage	polymer	 (since	 it	would	
release	incorrect	sugars	for	metabolism)	but	instead	acts	to	anchor	glycogen	to	the	glycogenin	core	
protein.	 Together,	 these	 three	 phases	 –	 prime-extend-refine	 –	 therefore	 appear	 to	 represent	 a	
mechanistic	solution	to	the	exquisite	evolutionary	balance	between	the	difficult-to-achieve	need	to	
anchor	glucose-polymer	to	a	protein	with	the	need	to	ensure	precise	glucose-only	particle	formation	
at	its	outer	regions.	
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The	 chemical	 ligation	 approach	 used	 here	 has	 shown	 that,	 whilst	 natural	 C–O	 Tyr195-to-
glucose	linkages	cannot	be	accessed	via	any	current	chemical	modification	approach	(ED	Figure	10),	
Pd-mediated	 formation	 of	 an	 irreversible	 C–C	 bond	 can	 yield	 sufficiently	 similar	 motifs	 to	 allow	
functional	mimicry	of	GYG	in	glycogenesis.	They	reveal	that	GYG’s	catalytic	activity	does	indeed	vary	
through	these	intermediate	states	and	highlight	how	this	‘self-modulation’	seems	to	be	exploited	by	
nature	in	three	phases	with	different	function.	We	anticipate	that	this	methodology	may	ultimately	
be	expanded	 to	now	access	 a	wider	 range	of	precise	 glycogen	 structures,	 enabling	 study	of	 other	
glucosylation	and	associated	processing	steps	that	will	shine	further	light	on	the	significant	and	ever-
expanding	number	of	glycogen-associated	diseases1,2,4,33.		
	 More	broadly,	the	demonstration	of	successful	mimicry	that	we	have	achieved	here	by	using	
Chemistry	 to	 covalently	 and	 directly	 ‘bolt	 in’	 a	 key	 residue	 alteration	 to	 create	 an	 intermediate	
catalytic	 state	highlights	 that	new	protein	 chemistries	are	becoming	precise	and	 subtle	enough	 to	
allow	 precise	 (e.g.	 ‘shunt’)	 mechanistic	 experiments	 that	 would	 be	 difficult	 through	 classical	
biochemical	 means.	 Although	 strategies	 for	 chemical	 rescue	 of	 enzymes	 via	 unmasking	 of	 caged	
natural	residues	have	been	elegantly	explored,19,34,35	 to	our	knowledge	these	mark	rare	application	
of	Pd-mediated	C–C-bond-forming	ligation	as	a	mode	of	chemical	enzyme	activation.	It	suggests	that	
such	 ligation-dependent	 activation	 (here	 using	 catalytic	 metal	 Pd(0)	 as	 a	 ‘switch’)	 could	 be	 a	
powerful	 tool	 not	 only	 in	 the	 study	 of	 mechanism	 but	 even	 potentially	 in	 the	 future	 ‘rescue’	 of	
deficient	enzymes.		
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Figure	Legends	
	
Figure	1	|	Palladium-mediated	C(sp
2
)–C(sp
2
)	ligation	as	a	strategy	for	mechanistic	investigation	of	
Glycogenin.	Amber	 codon	 suppression	enables	 “OH→I”	 replacement	of	 native	 Tyr195	acceptor	of	
GYG-wt	with	an	unnatural	L-p-iodophenylalanine	residue.	This	GYG-pIPhe195	enzyme,	which	lacks	a	
native	glycosyl	acceptor	and	thus	cannot	undergo	glucosylation,	represents	a	suitable	substrate	for	
Suzuki-Miyaura	 cross-coupling	 to	 a	 range	 of	 boronic	 acids	 sugar	 mimic	 templates,	 to	 generate	
potentially	 active	 enzyme	 species	 that	mimic	 defined	 GYG	 glycoforms.	 In	 this	 way,	 inactive	 GYG-
pIPhe195	might	be	activated	through	C–C	bond	forming	ligation	allowing	pre-determined,	‘shunted’	
access	to	intermediate	catalyst	states	of	GYG.	See	ED	Figures	2,4	for	templates.	
	
Figure	 2	 |	 Generation	 of	 homogeneously	 glucosylated,	 catalytically-active	 GYG	 glycoforms	 and	
kinetic	studies	of	GYG-Glc	and	GYG-GlcGlc.	 (a)	Pd-mediated	C–C	bond	forming	 ligation	of	glucose-
derived	boronic	acid	1-Glc	to	GYG-Y195pIPhe	generates	 in	good	yield	 the	homogeneous	glycoform	
GYG-Glc,	which	exhibits	catalytic	activity,	as	shown	by	LC-MS	analysis.	Similar	results	were	obtained	
for	 at	 least	 4	 independent	 repeats.	 In	 all	 cases,	 non-glucosylated	 side-products	 present	 show	 no	
activity	 in	 the	 assay.	 (b)	 Cross-coupling	 to	 1-GlcGlc	 instead	 enables	 direct,	 shunted	 access	 to	 a	
further	catalytic	intermediate	of	GYG-Glc,	GYG-GlcGlc,	which	also	proved	catalytically	active.	Similar	
results	were	obtained	for	at	least	5	independent	repeats.	In	all	cases,	non-glucosylated	side-products	
present	 show	 no	 activity	 in	 the	 assay.	 (c,d)	 Kinetic	 profiles	 of	 overall	 glucosylation	 (c)	 and	 initial	
glucosylation	step	as	monitored	through	consumption	of	starting	enzyme	(d	and	inset)	for	GYG-Glc	
and	GYG-GlcGlc.	Glucosylation	 levels	and	abundance	of	starting	enzyme	were	determined	through	
LC-MS	 analysis	 (see	 also	ED	 Figure	 6	 and	 Supplementary	Methods).	Whilst	 GYG-GlcGlc	 exhibits	 a	
marked	“fast	à	 slow”	biphasic	profile,	 these	same	phases,	whilst	necessarily	present	 for	GYG-Glc,	
are	not	visible,	being	instead	obscured	by	a	slower	initiation	step.	For	both	(c)	and	(d),	data	points	
represent	mean	averages	of	n	 independent	replicate	kinetic	runs;	n	=	4	 (GYG-Glc)	and	n	=	5	 (GYG-
GlcGlc).	Error	bars	are	±	s.d.	
	
	
Figure	3	|	Donor	and	acceptor	plasticity	of	GYG.	(a)	GYG-Glc	and	GYG-GlcGlc	are	capable	of	utilising	
the	 unnatural	 donor	 UDP-Galactose.	 Kinetic	 profiles	 for	 overall	 galactosylation	 (left)	 and	 rate	 of	
initial	 galactosylation	 step	 (right)	 are	 illustrated.	 Data	 points	 represent	 mean	 averages	 of	 n	 =	 3	
independent	replicate	kinetic	runs	for	both	GYG-Glc	and	GYG-GlcGlc	galactosylation.	Error	bars	are	±	
s.d.	 (b)	Generation	 of	 non-natural	 GYG	 glycosyl	 acceptors	 GYG-Gal	 and	 GYG-Man.	 Similar	 results	
were	 obtained	 for	 at	 least	 3	 independent	 repeats.	 (c)	Autoglucosylation	 activity	 of	 GYG-Man	 and	
GYG-Gal,	compared	to	GYG-Glc.	Kinetic	profiles	analogous	to	those	in	(a),	overall	glucosylation	(left)	
and	 rate	of	 initial	 glucosylation	 step	 (right)	are	 shown.	Data	points	 represent	mean	averages	of	 n	
independent	replicate	kinetic	runs;	n	=	4	(GYG-Glc)	and	n	=	3	(GYG-Gal,	GYG-Man).	Error	bars	are	±	
s.d.	In	all	cases,	non-glycosylated	side-products	present	show	no	activity	in	the	assay.	
	
Figure	4	|	Natural	and	unnatural	pathways	of	GYG	catalysis	further	delineate	triphasic	mechanism	
and	reveal	possible	proofreading	step.	(a)	Motion	of	Tyr195	to	accommodate	acceptor	substrates	of	
various	 lengths	 and	 conformations	 (intra-	 and	 inter-monomeric.	 Results	 obtained	 from	 MD	
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simulations	 for	 each	Michaelis	 complex.	 Acceptor	 sugar	 units	 have	 been	 omitted	 for	 clarity.	 The	
orange	 loop	corresponds	to	the	acceptor	arm	of	 the	same	subunit	of	 the	displayed	active	site	 (i.e.	
intra),	 whereas	 the	 white	 loop	 is	 the	 acceptor	 arm	 of	 the	 opposite	 subunit	 (inter).	 The	 tyrosine	
residue	represented	as	transparent	indicate	an	unstable	conformation	due	to	steric	hindrance	with	
the	 ‘blocking	 loop’	 coloured	 in	blue.	Notice	 that	 the	 tyrosine	 residue	 recoils	one	position	 for	each	
sugar	 that	 is	 attached	 to	 it.	 Hydrogen	 atoms	 and	 acceptor	 glucose	 units	 have	 been	 omitted	 for	
clarity.	(b)	Comparison	of	the	natural	autoglucosylation	pathway	[and	unnatural	autogalactosylation	
pathway	 for	 various	 GYG	 substrates]	 reveals	 that,	whilst	 the	 slower	 1st	 and	 3rd	 phases	 (which	we	
speculate	 are	 inter-monomer)	 display	 limited	 Gal-Gal	 transfer,	 this	 reaction	 readily	 proceeds	
throughout	the	fast	2nd	phase	(which	we	speculate	is	intra-monomer).	The	consequent	absence	of	a	
3rd	phase	for	autogalactosylation	may	function	as	a	‘refining’	step,	preventing	incorporation	of	poly-
Gal	oligosaccharides	into	glycogen	and	thus	preventing	accumulation	of	misformed,	potentially	toxic,	
glycogen	particles.		
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